For biopharmaceutical manufacturers considering pre-launch key opinion leader (KOL) engagement strategies, broadening your payer strategy to include network mapping will help you reach the clinical experts who help evaluate and shape guidelines and policies. This targeted approach, done in parallel to medical affairs provider outreach, is essential to optimize patient access.
Kathryne Kirk, Meghan Cioci, and Matthew Franceschini examine how network mapping analysis and tailoring outreach efforts can help these influencers gain access to compelling evidence and insights.
Read the full byline.
Complexity demands a trusted guide with the unique expertise and cross-sector versatility to deliver unwavering success. We work with organizations across regulated commercial and public sectors to catalyze transformation and pioneer new directions for the future.